Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

Completed · Phase 2 · Has a placebo group

Conditions studied: Hemorrhagic Shock

In brief

Based on encouraging results from animal studies, the investigators hypothesize that early administration of IV Premarin® in patients with hemorrhagic shock will safely reduce secondary injury, and improve survival.

Key facts

Study ID
NCT00973102
Run by
University of Texas Southwestern Medical Center
People needed
50
Starts
2009-07-01
Expected to finish
2012-05-01
Last updated by the study team
2020-03-19

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.